Trxade Group Inc. (TRXD) 1.7500 $TRXD
Trxade Group, Inc. Reports Increase in 2015 First Quarter Financial and Operational Results
ACCESSWIRE - Wed May 06, 9:26AM CDT
TAMPA, FL / ACCESSWIRE / May 6, 2015 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today its financial and operational results for first quarter 2015.
Taglich Brothers Issues Updated Research Report
ACCESSWIRE - Thu Apr 02, 6:15PM CDT
TAMPA, FL / ACCESSWIRE / April 2, 2015 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, On March 26th, 2015 filed their 10K Annual Report that reflects significant increase in revenues from 2013. Also announced today that Taglich Brothers published an updated report on Trxade Group, Inc. on March 31st, 2015.
TRxADE GROUP, INC. Expands its Board of Directors with Appointment of Independent Director
ACCESSWIRE - Wed Mar 18, 7:30AM CDT
TAMPA, FL / ACCESSWIRE / March 18, 2015 / Trxade Group, Inc., (OTCBB:TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today the appointment of Fernando Sanchez to the Company's Board of Directors. With this addition, the Trxade Group Board of Directors now comprises four directors; two of whom are independent directors.
Trxade Group, Inc. Expands its Board of Directors with Appointment of Independent Director
ACCESSWIRE - Tue Dec 23, 11:43AM CST
TAMPA, FL / ACCESSWIRE / December 23, 2014 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today the appointment of Donald V Almeida to the Company's Board of Directors. With these additions, the Trxade Group Board now comprises five directors; three of them are independent.
Trxade Group, Inc. Reports Q3 Results With Total Revenues Up 29% and Gross Profit Up 24% From Q2 2014
ACCESSWIRE - Fri Oct 31, 8:00AM CDT
TAMPA, FL / ACCESSWIRE / October 31, 2014 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling purchases between independent pharmacies and large pharmaceutical suppliers nationally, announced today its financial and operational results for third quarter 2014.
Trxade Group, Inc. Advances to Direct Sales Model Utilizing Existing Pharmaceutical Network
Marketwire - Tue Sep 30, 9:32AM CDT
Trxade Group, Inc. (OTCQB: TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced the launch of our new direct sales model through our wholly owned subsidiary, Westminster Pharmaceuticals, LLC. Westminster Pharmaceuticals will usher in an entirely new profit model for the company, allowing us direct market distribution for Private Label of Pharmaceuticals, pre-formulation, formulation development, scale-up, technical transfer of Tablets, Semi Solids, Oral Liquids, Topical applications and Non-sterile Liquids for Abbreviated New Drug Application/New Drug Application (ANDA/NDA) filing with Quality by Design (QBD) concept. In connection with this exciting new profit center, Dr. Ramesh Kenchappa, M.S.(Pharma), Ph.D., is joining the Company as Chief Scientific Officer. Dr. Ramesh will manage the Research & Development team at Westminster Pharmaceuticals.
Trxade Group Provides Trading Platforms to Pharmacies and Suppliers
Marketwire - Tue Sep 23, 1:00PM CDT
Trxade Group, Inc (OTCQB: TRXD) was recently added to the Bulletin Board and changed their ticker symbol to TRXD. Their CEO, Suren Ajjarapu, spoke with WSA about the company's recent activities and initiatives. He outlined TRXD's unique trading platforms and how they bring pharmaceutical buyers and sellers together by providing distribution solutions to independent pharmacies within a cloud-based environment. He explained that this allows for greater purchasing efficiency, pricing transparency, and means of product sourcing to meet their desired transaction needs. Mr. Ajjarapu outlined these three distinct platforms, S2P (supplier-to-pharmacy), P2P (pharmacy-to-pharmacy), and the most recently added, S2S (supplier-to-supplier). He stated that pharmacies do not have a well-defined means of product sourcing other than buying from their primary vendor and that Trxade offers them value, product availability, and a streamlined, centralized means of purchasing. He also discussed some of the company's recent service offerings, namely the RxGuru app and the Bulk Upload app, which enhance the purchasing efforts for pharma buyers by providing a user-friendly trading platform with proprietary data analytics that can show them the information on pharmaceuticals that are in short supply. He also identified recent market trends, discussed the company's goals for the upcoming year, and provided reasons why investors should consider the stock.
Trxade Group, Inc. Announces Launch of New Services
Marketwire - Wed Sep 03, 8:31AM CDT
Trxade Group, Inc., (OTCQB: TRXD), a web-based pharmaceutical marketplace enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that the Company has launched several new digital applications designed to enhance and improve our current services for both new and existing customers RxGuru app & BBU app (Bulk Upload)
Trxade Group, Inc. Changes Trading Symbol and Moves From OTC Pink to OTCQB
Marketwire Canada - Mon Aug 25, 8:45AM CDT
Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that the Company has moved from being an OTC Pink listed company to a fully reporting OTCQB company. The Company also changed its trading symbol from "XCEL" to "TRXD."
Trxade Group, Inc. Reports Increase in 2015 First Quarter Financial and Operational Results
ACCESSWIRE - Wed May 06, 9:26AM CDT
TAMPA, FL / ACCESSWIRE / May 6, 2015 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today its financial and operational results for first quarter 2015.
Taglich Brothers Issues Updated Research Report
ACCESSWIRE - Thu Apr 02, 6:15PM CDT
TAMPA, FL / ACCESSWIRE / April 2, 2015 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, On March 26th, 2015 filed their 10K Annual Report that reflects significant increase in revenues from 2013. Also announced today that Taglich Brothers published an updated report on Trxade Group, Inc. on March 31st, 2015.
TRxADE GROUP, INC. Expands its Board of Directors with Appointment of Independent Director
ACCESSWIRE - Wed Mar 18, 7:30AM CDT
TAMPA, FL / ACCESSWIRE / March 18, 2015 / Trxade Group, Inc., (OTCBB:TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today the appointment of Fernando Sanchez to the Company's Board of Directors. With this addition, the Trxade Group Board of Directors now comprises four directors; two of whom are independent directors.
Trxade Group, Inc. Expands its Board of Directors with Appointment of Independent Director
ACCESSWIRE - Tue Dec 23, 11:43AM CST
TAMPA, FL / ACCESSWIRE / December 23, 2014 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today the appointment of Donald V Almeida to the Company's Board of Directors. With these additions, the Trxade Group Board now comprises five directors; three of them are independent.
Trxade Group, Inc. Reports Q3 Results With Total Revenues Up 29% and Gross Profit Up 24% From Q2 2014
ACCESSWIRE - Fri Oct 31, 8:00AM CDT
TAMPA, FL / ACCESSWIRE / October 31, 2014 / Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling purchases between independent pharmacies and large pharmaceutical suppliers nationally, announced today its financial and operational results for third quarter 2014.
Trxade Group, Inc. Advances to Direct Sales Model Utilizing Existing Pharmaceutical Network
Marketwire - Tue Sep 30, 9:32AM CDT
Trxade Group, Inc. (OTCQB: TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced the launch of our new direct sales model through our wholly owned subsidiary, Westminster Pharmaceuticals, LLC. Westminster Pharmaceuticals will usher in an entirely new profit model for the company, allowing us direct market distribution for Private Label of Pharmaceuticals, pre-formulation, formulation development, scale-up, technical transfer of Tablets, Semi Solids, Oral Liquids, Topical applications and Non-sterile Liquids for Abbreviated New Drug Application/New Drug Application (ANDA/NDA) filing with Quality by Design (QBD) concept. In connection with this exciting new profit center, Dr. Ramesh Kenchappa, M.S.(Pharma), Ph.D., is joining the Company as Chief Scientific Officer. Dr. Ramesh will manage the Research & Development team at Westminster Pharmaceuticals.
Trxade Group Provides Trading Platforms to Pharmacies and Suppliers
Marketwire - Tue Sep 23, 1:00PM CDT
Trxade Group, Inc (OTCQB: TRXD) was recently added to the Bulletin Board and changed their ticker symbol to TRXD. Their CEO, Suren Ajjarapu, spoke with WSA about the company's recent activities and initiatives. He outlined TRXD's unique trading platforms and how they bring pharmaceutical buyers and sellers together by providing distribution solutions to independent pharmacies within a cloud-based environment. He explained that this allows for greater purchasing efficiency, pricing transparency, and means of product sourcing to meet their desired transaction needs. Mr. Ajjarapu outlined these three distinct platforms, S2P (supplier-to-pharmacy), P2P (pharmacy-to-pharmacy), and the most recently added, S2S (supplier-to-supplier). He stated that pharmacies do not have a well-defined means of product sourcing other than buying from their primary vendor and that Trxade offers them value, product availability, and a streamlined, centralized means of purchasing. He also discussed some of the company's recent service offerings, namely the RxGuru app and the Bulk Upload app, which enhance the purchasing efforts for pharma buyers by providing a user-friendly trading platform with proprietary data analytics that can show them the information on pharmaceuticals that are in short supply. He also identified recent market trends, discussed the company's goals for the upcoming year, and provided reasons why investors should consider the stock.
Trxade Group, Inc. Announces Launch of New Services
Marketwire - Wed Sep 03, 8:31AM CDT
Trxade Group, Inc., (OTCQB: TRXD), a web-based pharmaceutical marketplace enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that the Company has launched several new digital applications designed to enhance and improve our current services for both new and existing customers RxGuru app & BBU app (Bulk Upload)
Trxade Group, Inc. Changes Trading Symbol and Moves From OTC Pink to OTCQB
Marketwire Canada - Mon Aug 25, 8:45AM CDT
Trxade Group, Inc., (OTCQB: TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that the Company has moved from being an OTC Pink listed company to a fully reporting OTCQB company. The Company also changed its trading symbol from "XCEL" to "TRXD."
